Minnesota to get $4 million in Bristol-Myers Squibb settlement

Pioneer Press
By Jennifer Bjorhus

Pharmaceutical giant Bristol-Myers Squibb Co. is paying Minnesota $4.35 million to settle allegations of Medicaid fraud, the state Attorney General’s office announced Tuesday.

The Minnesota payment is part of a $515 million settlement the U.S. Department of Justice reached with New York-based Bristol-Myers last fall regarding Medicaid overpayments, the company said. Minnesota joined the settlement along with 42 other states.

The settlement resolved allegations that between the 1990s and 2005 Bristol-Myers and its former subsidiary Apothecon Inc. inflated prices for various prescription drugs covered by Medicaid, bribed doctors and health care providers to buy products and promoted using an antipsychotic drug called Abilify to treat children and dementia-related psychosis, which are uses the Food and Drug Administration hasn’t approved. The company was also accused of misreporting sales of an antidepressant called Serzone.

About these ads

Leave a comment

Filed under Uncategorized

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s